2
项与 Anti-BCMA CAR-T (The First Affiliated Hospital,Zhejiang University School of Medicine) 相关的临床试验B Cell Maturation Antigen(BMCA)-Targeted CAR-T for Refractory/Relapsed Multiple Myeloma
It's a single arm, open label prospective study, in which the safety and efficacy of B Cell Maturation Antigen(BMCA)-targeted CAR-T thearpy are evaluated in refractory/relapsed multiple myeloma patients.
Clinical and basic research on BCMA-CAR T cells in the treatment of multiple myeloma
100 项与 Anti-BCMA CAR-T (The First Affiliated Hospital,Zhejiang University School of Medicine) 相关的临床结果
100 项与 Anti-BCMA CAR-T (The First Affiliated Hospital,Zhejiang University School of Medicine) 相关的转化医学
100 项与 Anti-BCMA CAR-T (The First Affiliated Hospital,Zhejiang University School of Medicine) 相关的专利(医药)
100 项与 Anti-BCMA CAR-T (The First Affiliated Hospital,Zhejiang University School of Medicine) 相关的药物交易